A New York AI company teaching software to do the thing no litigation team has enough humans for: read tens of thousands of pages of medical records, build the timeline, and tie every conclusion back to the source page.
Here is a fact about complex litigation that nobody puts on a billboard: the case is often won or lost inside a stack of medical records so tall that no reasonable number of humans can read all of it carefully, quickly, and cheaply at the same time. Pick two. A plaintiff's firm evaluating a mass tort claim, or a defense team pricing its exposure, is really doing a document-review problem wearing a lawsuit costume. Parambil, a 14-person company in New York, has decided that this is the problem worth building an entire AI platform around.
The elevator version: Parambil ingests the unstructured mess of a medical file - hundreds of pages, sometimes 60,000 - and produces a structured, sourced, litigation-grade account of what happened to the patient and when. Timelines. Injury-causation links. Anomalies. Missed diagnoses. And crucially, every claim it makes points back to the page it came from, because an insight you cannot defend in front of a judge is, for litigation purposes, worth roughly nothing.
What makes this more than a summarization toy is the posture. Most legal AI reads a document and waits politely for your next prompt. Parambil ships agents - four of them - that keep working: they investigate, they draft, they research the clinical literature, they organize the file, and they re-check their own conclusions when a new record shows up. It is the difference between a very fast intern and a very fast intern who actually finishes the assignment and flags the parts they're unsure about.
You cannot hire enough humans to handle the volume while maintaining quality and speed.— Sara Dwyer, Co-Founder & CEO
In a demonstration the company likes to tell, Parambil was handed roughly 19,000 pages of medical records from a complex hysterectomy case. This is the kind of file that, done by hand, eats weeks of a nurse-reviewer's life and still risks missing something.
The platform found the primary surgical injury, which is what you'd hope. Then it found two additional missed diagnoses spread across separate emergency-room visits, plus a 10-day cascade of preventable complications that connected them.
The interesting part isn't that AI is fast. Everyone knows AI is fast. The interesting part is where the case-deciding fact lived: not on page one, not in the complaint, but buried somewhere in the middle of a five-figure page count where human attention reliably runs out.
In litigation math, a single missed diagnosis or an undocumented deviation from the standard of care can move a case's value by millions. So the pitch stops sounding like productivity software and starts sounding like a way to not leave seven figures on the table because nobody had time to read page 14,000.
Ingests and synthesizes unstructured records into clinical timelines and summaries, each event linked to its source page.
Automatic case screening, eligibility checks, claim tiering, and stratification across high-volume mass tort dockets.
Re-evaluates conclusions every time a new record lands, so the case file updates itself instead of going stale.
Data-visualization surface for timelines, injury patterns, and anomalies across a case or an entire portfolio of claims.
Ask the record questions in plain language and get answers grounded in the underlying documents.
Purpose-built for medical malpractice, birth injury, nursing-home abuse, and mass tort - each with its own clinical nuance.
Figures are company-reported. The bar widths are illustrative, not to a common scale.
The founding trio is the whole thesis in miniature: the hardest problems in complex litigation sit exactly where medicine and law overlap, which is precisely where general-purpose AI tends to fall apart. So Parambil put a physician in the founder's seat, not the advisor's.
Runs the company; background includes McKinsey. The public face of the argument that quality, speed, and volume can finally be had at once.
Founding engineer behind the agentic platform and the multi-model architecture that routes work to whichever AI does it best.
Former Chair of Medicine at both Yale and Stanford, with roughly three decades of clinical experience. The reason the software reads a chart like a doctor.
That's not incremental improvement - it's a fundamental shift in how complex cases are analyzed and resolved.— Ben Ling, Bling Capital (lead investor)
The temptation with legal AI is to make it sound confident, because confidence demos well. Parambil went the other way. Every agent is document-grounded, insights are tied to source material, and when the evidence is incomplete, the system flags the claim rather than papering over the gap with a plausible-sounding sentence.
In most software, admitting uncertainty is a weakness. In litigation, where a single invented citation can end a career and sink a case, building the honesty in is arguably the entire product. Defensibility - the ability to stand behind every line in front of a judge - is the feature everything else hangs on.
The second quiet decision: Parambil doesn't marry one model. It integrates Anthropic, OpenAI, Perplexity, and Google, and routes each task to whichever performs best for that specific slice of the work. It's a portfolio approach at a moment when most startups are betting the company on a single vendor.
And it sells to both sides. The same software that helps a plaintiff's firm find the missed diagnosis helps a defense team price its exposure. Parambil is, unusually, selling truth-in-the-record to whoever needs it - which is a defensible place to stand as the technology gets more powerful.
Led by Bling Capital, with NVP Capital and strategic angels across mass torts, personal injury, and legal-tech. Funds go to engineering, domain-specific AI workflows, and customer success.
Four autonomous agents - investigate, draft, research, organize - built with Anthropic, OpenAI, Perplexity, and Google. Covered by Law.com and the legal-tech press.
Expanding from hundreds of law firms into enterprise clients, including a major cruise line - the "transform healthcare in the process" half of the mission.
Official channels:
Watch - product demos & interviews:
Press & primary sources:
Dossier compiled from public sources, July 2026. Company-reported metrics noted as such. Where a detail could not be verified, it was left out.